This study also reported the generation and isolation of mAb 15A7.5, an anti–nectin-4 mAb chosen due to its observed selectivity toward nectin-4–expressing tumor cells in comparison with skin keratinocytes, as we hypothesized that less binding to keratinocytes would lead to less in vivo–associated clinical signs of skin toxicity. Here, NECTIN4 is linked to neoplasm.